Harvard Bioscience (HBIO) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.74 Bn | 121.52 Bn | 1.96 Bn | 112.62% |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn | -51.05% |
| 3 | Alcon | 33.18 Bn | 31.52 Bn | 1.53 Bn | -83.04% |
| 4 | Medline | 32.90 Bn | 30.67 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 56.15% |
| 6 | West Pharmaceutical Services | 23.15 Bn | 22.72 Bn | 329.20 Mn | -73.02% |
| 7 | Solventum | 14.12 Bn | 13.55 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn | -31.93% |
| 9 | Align Technology | 12.17 Bn | 11.11 Bn | 736.59 Mn | -7.28% |
| 10 | Harvard Bioscience | 27.29 Mn | 20.19 Mn | 12.24 Mn | -38.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.03% |
| Dec 31, 2025 | 57.16% |
| Sep 30, 2025 | 37.07% |
| Jun 30, 2025 | -31.48% |
| Mar 31, 2025 | -165.24% |
| Dec 31, 2024 | 85.17% |
| Sep 30, 2024 | -212.42% |
| Jun 30, 2024 | -345.15% |
| Mar 31, 2024 | -234.06% |
| Dec 31, 2023 | 46.24% |
| Sep 30, 2023 | -181.09% |
| Jun 30, 2023 | 49.05% |
| Mar 31, 2023 | 60.19% |
| Dec 31, 2022 | -37.59% |
| Sep 30, 2022 | -11.90% |
| Jun 30, 2022 | 395.77% |
| Mar 31, 2022 | -406.47% |
| Dec 31, 2021 | -50.67% |
| Sep 30, 2021 | -34.16% |
| Jun 30, 2021 | 29.96% |